SCHEMBL30784261

SCHEMBL30784261

Fc1ccc(Br)c(OC2CCSCC2)c1

nearest known ligand 0.51

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SCD O00767 17/20 0.51
SCD5 Q86SK9 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13730861 0.88 SCD (0.53) SCDSCD5
SCHEMBL4371504 0.81 SCD (0.51) SCDSCD5
SCHEMBL473045 0.81 HTR1A (0.51) SCD
SCHEMBL5341225 0.80 HRH1 (0.41) SCD
Hydrochloric Acid SCHEMBL3140594 0.79 HTR1A (0.50) SCD
SCHEMBL30784036 0.78 SCD (0.46) SCDSCD5
SCHEMBL3864751 0.77 SLC6A4 (0.51) SCD
SCHEMBL3100383 0.76 SCD (0.44) SCDSCD5
Hydrochloric Acid SCHEMBL2160831 0.75 SLC6A4 (0.50) SCD
SCHEMBL31050260 0.75 PDE4B (0.32) SCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024026424-A1 QUINAZOLINONE DERIVATIVES AS AND RELATED USES BLACK DIAMOND THERAPEUTICS, INC. (US) 2024-02-01 WO disclosed